These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29860382)

  • 1. Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).
    Dold M; Bartova L; Fugger G; Kautzky A; Souery D; Mendlewicz J; Papadimitriou GN; Dikeos D; Ferentinos P; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
    Int J Neuropsychopharmacol; 2018 Jun; 21(6):539-549. PubMed ID: 29860382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study.
    Dold M; Bartova L; Kautzky A; Serretti A; Porcelli S; Souery D; Mendlewicz J; Montgomery S; Zohar J; Kasper S
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1305-1313. PubMed ID: 30446357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression.
    Dold M; Bartova L; Kautzky A; Porcelli S; Montgomery S; Zohar J; Mendlewicz J; Souery D; Serretti A; Kasper S
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30677267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.
    Dold M; Bartova L; Mendlewicz J; Souery D; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
    Acta Psychiatr Scand; 2018 May; 137(5):401-412. PubMed ID: 29492960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study.
    Dold M; Bartova L; Fugger G; Mitschek MMM; Kautzky A; Frey R; Montgomery S; Zohar J; Mendlewicz J; Souery D; Fabbri C; Serretti A; Kasper S
    Eur Neuropsychopharmacol; 2020 Dec; 41():70-80. PubMed ID: 33046351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD).
    Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):752-760. PubMed ID: 29705022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression.
    Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109638. PubMed ID: 31054944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Prediction Model for Evaluating Treatment-Resistant Depression.
    Kautzky A; Baldinger-Melich P; Kranz GS; Vanicek T; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Lanzenberger R; Kasper S
    J Clin Psychiatry; 2017 Feb; 78(2):215-222. PubMed ID: 28068461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice.
    Bartova L; Dold M; Kautzky A; Fabbri C; Spies M; Serretti A; Souery D; Mendlewicz J; Zohar J; Montgomery S; Schosser A; Kasper S
    World J Biol Psychiatry; 2019 Jul; 20(6):427-448. PubMed ID: 31340696
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study.
    Dold M; Bartova L; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
    J Psychiatr Res; 2017 Aug; 91():1-13. PubMed ID: 28284107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melancholic features in major depression - a European multicenter study.
    Dold M; Bartova L; Fugger G; Kautzky A; Mitschek MMM; Fabbri C; Montgomery S; Zohar J; Souery D; Mendlewicz J; Serretti A; Kasper S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110285. PubMed ID: 33609603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study.
    Dold M; Kautzky A; Bartova L; Rabl U; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1960-1971. PubMed ID: 27816317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.
    Kautzky A; Dold M; Bartova L; Spies M; Kranz GS; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fabbri C; Serretti A; Lanzenberger R; Dikeos D; Rujescu D; Kasper S
    Acta Psychiatr Scand; 2019 Jan; 139(1):78-88. PubMed ID: 30291625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study.
    Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):777-785. PubMed ID: 31006562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study.
    Schosser A; Carlberg L; Calati R; Serretti A; Massat I; Spindelegger C; Linotte S; Mendlewicz J; Souery D; Zohar J; Montgomery S; Kasper S
    Int J Neuropsychopharmacol; 2017 Oct; 20(10):782-787. PubMed ID: 28977521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melancholic features and hostility are associated with suicidality risk in Asian patients with major depressive disorder.
    Jeon HJ; Peng D; Chua HC; Srisurapanont M; Fava M; Bae JN; Man Chang S; Hong JP
    J Affect Disord; 2013 Jun; 148(2-3):368-74. PubMed ID: 23414572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study.
    Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):625-632. PubMed ID: 28579072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study.
    Dold M; Bartova L; Fugger G; Mitschek MM; Fabbri C; Serretti A; Mendlewicz J; Souery D; Zohar J; Montgomery S; Kasper S
    J Affect Disord; 2022 Jan; 296():485-492. PubMed ID: 34653701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression.
    Bartova L; Dold M; Fugger G; Kautzky A; Mitschek MMM; Weidenauer A; Hienert MG; Frey R; Mandelli L; Zohar J; Mendlewicz J; Souery D; Montgomery S; Fabbri C; Serretti A; Kasper S
    Depress Anxiety; 2021 Sep; 38(9):896-906. PubMed ID: 34110066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.